"Every day, I got on the scales and I still weighed exactly the same as before," Leith, 85, told U.K. paper 'The Times' ...

Determining the type of diabetes a patient has at diagnosis can be challenging, and health care professionals should focus on ...

The healthcare industry has proven to be a resilient place for investors to put cash to work over the years. If you are ...

Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO stock is a buy.

Pfizer is suing Novo Nordisk following the Danish pharma's last-minute bid to acquire Metsera, which Pfizer called “reckless” ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

An astonishing fact about the GLP-1 meds that are helping millions lose weight: Tirzepatide, the active ingredient in ...

Pfizer filed an antitrust lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

The U.S. stock market sank from record heights as Wall Street sifted through mixed developments on everything from the ...

Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.